cyclosporine has been researched along with Rheumatism in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (51.28) | 18.2507 |
| 2000's | 11 (28.21) | 29.6817 |
| 2010's | 6 (15.38) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, SCS; Lee, JSS; Tan, LS; Tee, SI | 1 |
| Baldini, C; Bootsma, H; Bowman, SJ; Brito-Zerón, P; De Vita, S; Dörner, T; Fisher, BA; Gottenberg, JE; Hernández-Molina, G; Kocher, A; Kostov, B; Kruize, AA; Mandl, T; Mariette, X; Ng, WF; Ramos-Casals, M; Retamozo, S; Seror, R; Shoenfeld, Y; Sisó-Almirall, A; Tzioufas, AG; Vissink, A; Vitali, C | 1 |
| Barsotti, S; Mosca, M; Neri, R; Pollina, LE; Tripoli, A | 1 |
| Bazzani, C; Benucci, M; Caporali, R; Galeazzi, M; Giannitti, C; Manganelli, S; Scarpato, S; Sebastiani, GD | 1 |
| Hwang, KP; Kuo, HC; Sheen, JM; Yang, KD; Yeap, ST; Yu, HR | 1 |
| Ben m'rad, M; Gherissi, D; Mouthon, L; Salmon-Céron, D | 1 |
| Abdelhaleem, M; Benseler, S; Gupta, AA; Tyrrell, P; Valani, R; Weitzman, S | 1 |
| Mimori, T | 1 |
| Brozmanova, H; Grundmann, M; Koristkova, B; Mayer, O; Perinova, I; Suchy, D | 1 |
| Yamaji, K | 1 |
| Brozmanova, H; Dostalek, M; Grundmann, M; Mayer, O; Perinova, I; Suchy, D; Vyskocil, V | 1 |
| Marson, P; Pasero, G | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Dadlani, C; Orlow, SJ | 1 |
| Hanaoka, R; Ide, H; Isozaki, T; Kasama, T; Matsunawa, M; Miwa, Y; Negishi, M; Shiozawa, F; Yajima, N; Yoda, Y | 1 |
| Emery, H; Grenert, J; Hermiston, M; Lam, W; Modica, R; von Scheven, E; Wirt, M | 1 |
| Bellisai, F; Galeazzi, M; Giannitti, C; Manganelli, S; Morozzi, G; Sebastiani, GD | 1 |
| Szechiński, J; Wiland, P | 1 |
| Zabel, P | 1 |
| Sewell, KL | 1 |
| Capkova, J; Eulderink, F; Gaede, K; Heesemann, J; Hoebe-Hewryk, B; Kievits, F; Pla, M; van Alphen, L; Weinreich, S; Zurcher, C | 1 |
| Nasonov, EL; Nasonova, VA; Shtutman, VZ | 1 |
| Lewandowska-Furmanik, M; Misztal, S; Toczołowski, J | 1 |
| Friedman, AW; McCune, WJ | 2 |
| Gross, WL; Rob, PM | 1 |
| Bermas, BL; Hill, JA | 1 |
| Ramsey-Goldman, R; Schilling, E | 1 |
| Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
| Fantini, F; Gattinara, M; Gerloni, V; Lomater, C; Mazzotti, J | 1 |
| Scott, DG; Somerville, MF | 1 |
| Nasonov, EL; Tareeva, IE | 1 |
| Balow, JE; James, SP; Klippel, JH; Langford, CA; Sneller, MC | 1 |
| Padovan, M; Trotta, F | 1 |
| Callen, JP | 1 |
| Kohno, K; Saito, K; Tanaka, Y; Tujimura, S | 1 |
| Jaffe, IA | 1 |
| Buskila, D; Shoenfeld, Y; Sukenik, S | 1 |
| Corvetta, A; Della Bitta, R; Luchetti, MM; Pomponio, G | 1 |
22 review(s) available for cyclosporine and Rheumatism
| Article | Year |
|---|---|
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's Syndrome.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Rheumatic Diseases; Sjogren's Syndrome | 2021 |
Histopathology of the muscle in rheumatic diseases.
Topics: Adrenal Cortex Hormones; Biopsy; Connective Tissue Diseases; Cyclosporine; Diagnosis, Differential; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Immunohistochemistry; Muscle, Skeletal; Muscular Diseases; Penicillamine; Rheumatic Diseases; Staining and Labeling; Vasculitis | 2018 |
Treatment of rheumatic diseases in patients with HCV and HIV infection.
Topics: Antibodies; Cyclosporine; Hepatitis C, Chronic; HIV Infections; Humans; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2008 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 7. Cyclosporine].
Topics: Collagen Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Rheumatic Diseases | 2011 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
Topics: Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Hepatitis C; Humans; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2007 |
[Pathogenesis of interstitial pulmonary changes with collagen diseases--therapeutic implications].
Topics: Adrenal Cortex Hormones; Antigen-Antibody Complex; Antimetabolites; Autoantibodies; Autoantigens; Autoimmune Diseases; Colchicine; Collagen Diseases; Cyclosporine; Cytokines; Humans; Immunity, Cellular; Lung Diseases; Lymphocytes; Macrophages; Monocytes; Pentoxifylline; Pulmonary Alveoli; Rheumatic Diseases; Vasculitis | 1995 |
Immunotherapy and other novel therapies, including biologic response modifiers, apheresis, and dietary modifications.
Topics: Antibodies, Monoclonal; Blood Component Removal; Cyclosporine; Humans; Iloprost; Immunotherapy; Interferons; Peptides; Rheumatic Diseases; Tacrolimus | 1993 |
[Prospects of the use of cyclosporin A in rheumatic diseases].
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Rheumatic Diseases; Sjogren's Syndrome | 1994 |
Immunosuppressive drug therapy for rheumatic disease.
Topics: Cyclophosphamide; Cyclosporine; Cytarabine; Humans; Immunosuppressive Agents; Rheumatic Diseases | 1993 |
[Cyclosporin A in inflammatory rheumatic diseases].
Topics: Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Immune Tolerance; Immunosuppressive Agents; Rheumatic Diseases; Treatment Outcome | 1996 |
Effects of immunosuppressive drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infertility, Female; Mercaptopurine; Methotrexate; Mice; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1995 |
Immunosuppressive drug use during pregnancy.
Topics: Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1997 |
Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases.
Topics: Autoimmune Diseases; Cell Survival; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Diseases; Rheumatic Diseases; United States | 1998 |
[Trends in the treatment of rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclooxygenase Inhibitors; Cyclosporine; Hand; Humans; Immunoglobulins, Intravenous; Knee Joint; Methotrexate; Osteoarthritis; Plasmapheresis; Radiography; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 1999 |
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Chlorambucil; Cladribine; Cyclophosphamide; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Skin Diseases; Thioguanine | 2001 |
[Clinical implication of cyclosporin for systemic autoimmune diseases: relevance to multidrug resistance].
Topics: Autoimmune Diseases; Collagen Diseases; Cyclosporine; Genes, MDR; Humans; Rheumatic Diseases | 2002 |
New approaches to the management of rheumatoid arthritis.
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Arthritis, Rheumatoid; CD4 Antigens; Cyclosporine; Drug Therapy, Combination; Humans; Immunotherapy; Magnetic Resonance Imaging; Methotrexate; Photochemotherapy; Rheumatic Diseases; Rheumatology | 1992 |
Immunosuppressive drug therapy for rheumatic disease.
Topics: Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; Rheumatic Diseases | 1992 |
The possible role of prolactin in autoimmunity.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Psoriatic; Autoantibodies; Autoimmune Diseases; Autoimmunity; Bromocriptine; Cyclosporine; Drug Synergism; Female; Humans; Hyperprolactinemia; Immunity, Cellular; Immunocompetence; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Pregnancy; Pregnancy Complications; Prolactin; Rats; Rheumatic Diseases; Uveitis | 1991 |
1 trial(s) available for cyclosporine and Rheumatism
| Article | Year |
|---|---|
Neoral--new cyclosporin for old?
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Behcet Syndrome; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy; Emulsions; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Rheumatic Diseases; Severity of Illness Index; Surveys and Questionnaires | 1997 |
16 other study(ies) available for cyclosporine and Rheumatism
| Article | Year |
|---|---|
Fibroblastic Rheumatism Versus Variant Disease of Multinucleate Cell Angiohistiocytoma.
Topics: Antirheumatic Agents; Cyclosporine; Diagnosis, Differential; Female; Fibroblasts; Giant Cells; Hemangioma; Histiocytoma; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Rheumatic Diseases; Skin Diseases; Skin Neoplasms | 2020 |
Macrophage activation syndrome as initial presentation of systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Antinuclear; Cyclosporine; Female; Humans; Immune System Diseases; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Rheumatic Diseases; Syndrome | 2008 |
[Tuberculosis risk among patients with systemic diseases].
Topics: Antibodies, Monoclonal; Antitubercular Agents; Cyclophosphamide; Cyclosporine; France; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Japan; Mycophenolic Acid; Rheumatic Diseases; Risk Factors; Spain; Sweden; Tuberculin Test; Tuberculosis; Tumor Necrosis Factor-alpha; United States | 2009 |
Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Topics: Adolescent; Adrenal Cortex Hormones; Cause of Death; Child; Child, Preschool; Cyclosporine; Etoposide; Female; Hematologic Neoplasms; Humans; Immunoglobulins, Intravenous; Infant; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Retrospective Studies; Rheumatic Diseases; Steroids; Virus Diseases | 2009 |
Cyclosporine A area-under-time-concentration-curve in rheumatologic patients after the first dose. Which of the sparse sampling strategies will predict the best?
Topics: Adult; Aged; Antirheumatic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Reproducibility of Results; Rheumatic Diseases | 2011 |
Single-dose and steady state pharmacokinetics of CSA and two main primary metabolites, AM1 and AM4n in patients with rheumatic/autoimmune diseases.
Topics: Area Under Curve; Autoimmune Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Rheumatic Diseases | 2011 |
A short story of anti-rheumatic therapy. VIII. The immunodepressants.
Topics: Alkylating Agents; Allergy and Immunology; Antimetabolites; Antirheumatic Agents; Cyclosporine; Folic Acid Antagonists; Graft Rejection; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rheumatic Diseases; Thalidomide | 2012 |
Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Connective Tissue Diseases; Cyclophosphamide; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Opportunistic Infections; Pneumocystis Infections; Pulse Therapy, Drug; Rheumatic Diseases | 2006 |
Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
Topics: Antirheumatic Agents; B-Lymphocytes; Cyclosporine; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Infant; Infant, Newborn; Inflammation; Lymphoproliferative Disorders; Rheumatic Diseases; Syndrome | 2006 |
N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biomarkers; Connective Tissue Diseases; Cyclosporine; Female; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Organogold Compounds; Prednisone; Respiratory Tract Infections; Rheumatic Diseases; Urinary Tract Infections | 1994 |
HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice.
Topics: Age Factors; Animals; Biomarkers; Cyclosporine; Female; H-2 Antigens; HLA-B27 Antigen; Housing, Animal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Rheumatic Diseases; Risk Factors; Sex Factors | 1995 |
[Local use of cyclosporin in nonbacterial corneal ulceration].
Topics: Anti-Infective Agents, Local; Corneal Transplantation; Corneal Ulcer; Cyclosporine; Female; Humans; Middle Aged; Rheumatic Diseases; Sjogren's Syndrome | 1993 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
Cyclosporin in pediatric rheumatology; a seven years experience.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Creatine; Cyclosporine; Dermatomyositis; Female; Humans; Infant; Iridocyclitis; Male; Panniculitis; Rheumatic Diseases; Thrombocytopenia | 1994 |
[The outlook for the use of cyclosporin A in rheumatology and nephrology].
Topics: Antirheumatic Agents; Cyclosporine; Humans; Kidney Diseases; Renal Agents; Rheumatic Diseases | 1997 |
5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases.
Topics: 5-Methylcytosine; Adult; Autoimmune Diseases; Chromatography, High Pressure Liquid; Cyclosporine; Cytosine; DNA; Female; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Methylation; Middle Aged; Rheumatic Diseases; Synovial Membrane | 1991 |